BioSpace News Archive

Drug Development

Genentech Presents New Ocrevus (Ocrelizumab) Biomarker Data That Increase Understanding of Disease Progression in Multiple Sclerosis at ECTRIMS

Genentech, a member of the Roche Group, announced new data from Ocrevus® trials in relapsing and primary progressive multiple sclerosis.

September 10, 2019
·
12 min read
Deals

QIAGEN Announces Change in Global Sales Structure

QIAGEN N.V. announced that it has decided to integrate its global sales resources into its Business Areas.

September 10, 2019
·
4 min read
Drug Development

Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo’s DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer

Daiichi Sankyo Company, Limited announced the presentation of updated phase 1 clinical results and new biomarker data for DS-1062, an investigational TROP2 targeting antibody drug conjugate (ADC), in 52 unselected patients with heavily pretreated advanced non-small cell lung cancer (NSCLC).

September 10, 2019
·
10 min read
Business

Be The Match BioTherapies® and Celyad Announce Collaboration to Advance Development of Allogeneic CAR-T Therapies

Alliance will support the clinical progression of Celyad’s non-gene edited allogeneic CAR-T candidates

September 10, 2019
·
4 min read
Genetown

Alnylam Presents New Clinical Results for Givosiran at the 2019 International Congress on Porphyrins and Porphyrias

Alnylam Pharmaceuticals, Inc., announced that the Company and its collaborators presented new clinical results at the 2019 International Congress on Porphyrins and Porphyrias, held September 8-11, 2019 in Milan, Italy.

September 10, 2019
·
14 min read
European Semifinalist of SEED AWARD was Unveiled, Highlighting the Integration of Technology and Humanity

SEED AWARD, launched by Seedland Group, held its European Semifinal on September 5, 2019, in London, where ten teams competed for three entries to the Global Final.

September 10, 2019
·
2 min read
Pharm Country

Dreem launches the first sleep healthcare solution to tackle sleep problems at scale

Dreem 2 is a holistic, non-invasive solution, which includes an FDA-registered medical device to help poor sleepers address their problems and improve their sleep.

September 10, 2019
·
3 min read
Biotech Beach

FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement for biotherapeutic development

Delivers enhanced galactosylation for improved protein quality, and antibody binding and function

September 10, 2019
·
2 min read
BioMidwest

Cologuard® Helps More People Get Screened In A Cost-Effective Way

Exact Sciences announced that nearly 3 million people have been screened for colorectal cancer with Cologuard since FDA approval with half of those tested being previously unscreened.

September 10, 2019
·
8 min read
Biotech Bay

Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis

University of California, Davis Study Shows up to 98% Reduction of Intestinal Inflammation Markers Linked to Colic, Eczema, Asthma and Diabetes

September 10, 2019
·
5 min read